UTC Investment, established in 1988 and based in Seoul, South Korea, is a prominent asset manager specializing in private equity investments. The firm has a strong focus on buyouts and has built a diversified portfolio that includes venture capital and growth equity investments. UTC Investment targets various sectors, including biotechnology, healthcare, lifestyle, information technology, and semiconductors. With a robust track record, it has positioned itself as a leading global investment firm, leveraging its expertise to implement and develop strategic investment opportunities.
Pebble Square's new Processing-In-Memory (PIM) architecture is a significant advancement for AI performance and power efficiency.
WASHSWAT
Series C in 2024
Washswat Inc. is a South Korean company established in 2015 that specializes in on-demand mobile laundry services. Based in Seoul, it operates through a network of specialized facilities and personnel that handle washing and drying. Initially launched in the Gangnam area, known for its concentration of high-end cleaners, Washswat has strategically expanded its services to various regions, including Seongnam, Hanam, Goyang, Gwangmyeong, Yongin, Suwon, Anyang, and Gwacheon, becoming a leader in mobile laundry services in Korea. The company utilizes IT technology to enhance its offerings, providing customers with a mobile application that allows them to track their laundry process and schedule pickups and deliveries from their doorstep. Washswat's meticulous approach ensures that every item is carefully recorded to prevent loss, thereby delivering a reliable service tailored to meet customer needs.
Solmedix
Venture Round in 2024
Solmedix is a company focused on the development and commercialization of innovative medical devices aimed at enhancing treatment and diagnostic capabilities. Utilizing its MOSAIC Platform, Solmedix provides a range of services that include evaluating medical device concepts, producing prototypes, securing patents, and conducting empirical and preclinical research. The company supports the entire lifecycle of medical device development, from initial idea diagnosis to technology transfer and product launch. By offering these comprehensive services, Solmedix aims to facilitate the successful commercialization of startups with promising medical device concepts.
Lucas
Series B in 2024
Lucas develops a system to detect, measure, categorize and track nodules in the screening CT images.
Allround Doctors
Series A in 2024
Allround Doctors is a digital healthcare startup that develops digital medical devices for cancer patients.
Bold9
Series B in 2024
Bold9 specializes in providing logistics services tailored for online sellers. The company aims to create a comprehensive platform that enhances the logistics process for its clients. By focusing on optimizing logistics requirements and facilitating product sourcing, Bold9 enables online sellers to ensure timely fulfillment of their deliveries, thereby improving overall efficiency in their operations.
Nventric
Series B in 2024
Nventric is a medical device company focused on developing innovative solutions for neurovascular, coronary heart, and peripheral vascular applications. The company's primary product is designed to remove blood clots that lead to ischemic strokes. This device utilizes a stent retriever that can be inserted into the artery in the leg, allowing physicians to effectively access and remove blood clots responsible for arterial occlusion. By enhancing the treatment process for ischemic stroke, Nventric aims to improve patient outcomes and advance medical care in vascular conditions.
GexVal
Series C in 2023
GEXVal Inc. is a drug discovery company based in Fujisawa, Japan, founded in 2018. The company focuses on the research and development of innovative treatments for rare and incurable diseases, particularly in the fields of psychiatry, neurology, and pulmonary arterial hypertension. GEXVal aims to enhance the health and quality of life for patients and families affected by these challenging conditions by providing cost-effective treatment options. Through its commitment to addressing the needs of those with intractable diseases, GEXVal strives to make a meaningful impact in the realm of healthcare.
Edgecare
Series A in 2023
Edgecare is a manufacturing company that develops medical, precision, monitoring, and optical devices for the healthcare industry.
Novorex
Series A in 2023
Novorex focuses on developing small-molecule drugs aimed at treating oncology and neurology diseases. The company employs advanced technologies, including artificial intelligence, to enhance drug development processes. By integrating biophysical analysis with in vitro and in vivo assays, Novorex aims to improve the efficacy of its new treatments, ultimately providing patients with innovative solutions for cancer and central nervous system disorders.
Brexogen
Series C in 2023
Brexogen is a biotechnology company focused on the research and development of cell therapies aimed at treating incurable diseases through the use of stem cell exosomes. The company specializes in creating optimized parental cells that enhance exosome production, exhibiting superior proliferation and secretion capabilities compared to traditional stem cells. This innovation allows for a more effective system for mass production of exosomes, which is essential for advancing their commercialization. Brexogen’s work aims to provide new therapeutic options for patients suffering from challenging medical conditions.
Right Route
Seed Round in 2023
Right Route is an e-commerce company for clothes.
Exorenal
Seed Round in 2023
Exorenal is a medical device company based in the United States that specializes in the development of artificial kidney machines and kidney dialysis devices. The company focuses on the point-of-care hemodialysis machine market, creating a novel hemodialysis unit featuring a fully disposable dialysate compartment. This innovation addresses the growing demand for home-based hemodialysis solutions by enhancing convenience, reducing complexity, and ensuring a lightweight design. Exorenal's products are designed to improve the overall experience of patients undergoing hemodialysis at home.
Brexogen
Venture Round in 2023
Brexogen is a biotechnology company focused on the research and development of cell therapies aimed at treating incurable diseases through the use of stem cell exosomes. The company specializes in creating optimized parental cells that enhance exosome production, exhibiting superior proliferation and secretion capabilities compared to traditional stem cells. This innovation allows for a more effective system for mass production of exosomes, which is essential for advancing their commercialization. Brexogen’s work aims to provide new therapeutic options for patients suffering from challenging medical conditions.
iChems
Venture Round in 2023
iChems is a company focused on the research and development of precursor materials specifically designed for semiconductor wafers. It manufactures substances utilized in atomic layer deposition and organic metallurgical processes. With a strong reputation, iChems supplies a range of precursor products to major semiconductor companies and their manufacturing affiliates in Korea. The company’s expertise in developing innovative materials positions it as a key player in the semiconductor industry.
FatiAbGen
Seed Round in 2023
FatiAbGen is an innovative company focused on developing monoclonal antibody-based therapies for the treatment of oncology and allergy-related diseases, as well as immunological disorders and infectious diseases. The company boasts a comprehensive pre-clinical pipeline that utilizes advanced therapeutic antibodies. FatiAbGen specializes in enhancing linker technology to improve the delivery of therapeutic payloads to solid tumors, while also addressing issues related to immunogenicity and toxicity. By regulating stem cell fate, the company aims to provide effective relief for patients suffering from various cancers and immunological conditions.
Nuvilab
Series A in 2022
Nuvilab specializes in digital solutions for the food industry, focusing on environmental sustainability and enhancing personal well-being. The company offers an AI-powered food scanner that can instantly identify food types and volumes, facilitating accurate food analysis. By harnessing big data, Nuvilab integrates various food-related information, such as details about leftovers, user preferences, and nutritional benefits. This comprehensive approach allows the company to provide personalized nutritional reports and tailored guidelines, promoting healthier dietary habits among users.
Avelos Therapeutics
Series A in 2022
Avelos Therapeutics is a clinical-stage precision medicine company that specializes in the development of biomarker-driven anti-cancer therapies. The company focuses on creating targeted therapeutics that address critical areas such as cell cycle regulation, DNA damage response, and undruggable cancer targets. By leveraging these innovative approaches, Avelos aims to enhance the effectiveness of cancer treatment, allowing healthcare professionals to provide more tailored and efficient care to patients.
MDSquare
Seed Round in 2022
MDSquare is a mobile telemedicine consultation service company.
GSIL Co.
Series A in 2022
GSIL Co., Ltd. specializes in safety management technology tailored for the construction industry. The company offers a comprehensive safety solution known as Saint, which utilizes real-time IoT technology to monitor the location and status of workers, as well as to manage equipment through NFC tags. This platform enables safety managers to precheck hazardous factors, analyze the likelihood of accidents, and respond effectively to crises based on accurate data. By addressing the specific needs of field workers, GSIL aims to enhance safety measures, reduce overtime, and ultimately promote a culture of safety in the workplace. Their mission, encapsulated in the phrase "Good Safety in Life," reflects their commitment to providing effective safety solutions that improve the overall well-being of workers in hazardous environments.
Rznomics
Series C in 2022
Rznomics is a biotechnology company founded by professor Lee Sung-wook's lab, focusing on the development of innovative gene therapy products aimed at treating liver cancer and other serious medical conditions. The company specializes in ribonucleic acid-based therapies that address significant unmet medical needs, particularly in the areas of cancer, degenerative neurological disorders, and hereditary diseases. By creating new biopharmaceuticals, Rznomics aims to provide medical practitioners with effective treatment options for challenging health issues, including various types of cancer and Alzheimer’s disease. The company has garnered recognition for its technological excellence, having been selected for the TIPS program, which highlights its commitment to advancing medical science.
Armored Fresh
Series A in 2022
Armored Fresh is a food company that specializes in producing plant-based cheese made from almond milk. Committed to sustainability, the company aims to create cheese alternatives that are beneficial for both people and animals. By leveraging advanced technology, Armored Fresh has developed a vegan cheese that closely mimics the taste and texture of traditional dairy cheese. The product line includes vegan cube cheese characterized by a soft texture and savory flavors, designed to enhance nutritional content and protein levels comparable to cow cheese. Through its offerings, Armored Fresh seeks to promote health and well-being while also protecting the environment.
Vendit
Seed Round in 2022
Vendit provides automation solutions for the hospitality industry, focusing on hotels to help them reduce labor costs and enhance revenue. The company manufactures self-operating kiosks and cloud management systems designed for online reservations and check-ins. Vendit's technology employs AI for adult authentication and features automatic key technology that integrates with online travel agencies. Additionally, it offers automatic dashboards, allowing businesses to automate repetitive tasks and streamline operations effectively. This approach not only improves efficiency but also supports hotels in maximizing their sales potential.
Precious Writing
Seed Round in 2022
Precious Writing is an e-learning platform that offers language education solutions using big data and artificial intelligence.
Selecxine
Series B in 2022
Selecxine is a biopharmaceutical development company focused on creating innovative immunotherapeutics for cancer treatment. The company specializes in the development of anti-cancer drugs that enhance the immune response by regulating cytokine functions, which are crucial for activating immune cells. Through its advanced platform technology, Selecxine employs a unique antibody development process to discover and develop these therapeutics. The goal is to provide safe and effective treatment options that improve both the survival rates and quality of life for cancer patients.
Autotelic Bio
Series B in 2022
Autotelic Bio is a biotechnology company dedicated to researching and developing innovative anti-cancer drugs. The company aims to enhance the efficacy and reduce the side effects of existing oncology treatments by focusing on precise targeting and optimization of therapies. In addition to its primary focus on cancer, Autotelic Bio seeks to expand its research efforts into immuno-oncology drugs that may also address conditions such as diabetes, hypertension, and diseases affecting the central nervous system. Through its specialized approach, Autotelic Bio is committed to improving treatment options for patients facing various health challenges.
We Hudling
Series A in 2022
Wehuddling provides corporate and individual breakfast and lunch subscriptions. The company offers secure and free meal shipping services.
BnH Research
Series B in 2022
BnH Research is a drug development and research firm focused on creating therapeutics for patients with chronic conditions. The company specializes in verifying the efficacy of new drug candidates and improving patient outcomes. It provides contract-based research services aimed at validating drug efficacy data, addressing the unmet needs of pharmaceutical companies. Additionally, BnH Research develops drug candidates with a particular emphasis on reopening cortical plasticity, which aids clients in targeting central nervous system conditions such as Alzheimer's Disease, PTSD, addiction, amblyopia, and stroke. Through its innovative approach, BnH Research contributes to advancing therapeutic options for complex health issues.
Coactus
Seed Round in 2022
Coactus is a social venture that creates an innovative business to make a better world. They do deaf taxi driver's taxi service, 'Goyohan Taxi'. In order to help communicate with passengers, they developed a communication tool 'Goyohan', which operates in two tablet PC's inside the taxi. Goyohan Taxi has 26 deaf taxi drivers in 5 areas, with 10 taxi companies. Within 2020, they aim to create 100 deaf taxi drivers.
Vastera
Series B in 2022
Bastera is a biotech company with the primary goal of developing groundbreaking treatments for cardiovascular and cancer diseases. Their approach involves targeting new redox signaling pathways, aiming to pioneer "first-in-class" therapies in these fields. Vastera was established in 2018 when SangWon Kang, a professor at Ewha Womans University, transferred a patent based on research results on redox signaling in blood vessels and cancer.
Wefun
Venture Round in 2022
Wefun is a company focused on managing office snacks, offering a diverse selection to meet the tastes of employees. They employ a dedicated snack curator who conducts personalized consultations to understand client preferences and recommend new products. This tailored approach allows businesses to order weekly snacks that align with the specific tastes of their workforce, enhancing the overall workplace experience.
Pinpoint
Venture Round in 2022
Pinpoint is a proptech company focused on developing small and medium-sized office spaces. It aims to revolutionize the office market by integrating space and digital technologies to enhance user experience. The company provides a space-based service platform that offers various digital functions and spatial content, facilitating improved communication and management for building owners, operators, lessees, and users. Through its innovative approach, Pinpoint addresses the gaps in digital transformation within the office sector, offering solutions that meet the evolving needs of modern work environments.
TMD Lab
Venture Round in 2022
TMD Lab focuses on the research and development of advanced medical devices and biomedicine utilizing shape memory polymer and nanovesicle technology. The company specializes in creating customized products that can adapt to the unique shapes of individuals or objects. This innovative approach allows TMD Lab to serve a diverse range of industries, including healthcare, printing, textiles, and materials, thereby enhancing product functionality and promoting better health outcomes. Through its cutting-edge technology, TMD Lab aims to drive innovation and improve the efficacy of various applications.
CT Cells
Venture Round in 2022
CT Cells is a total solution provider from precise diagnostics to personalized therapeutics.
Lucas
Series A in 2021
Lucas develops a system to detect, measure, categorize and track nodules in the screening CT images.
Creatz
Series A in 2021
Creatz is a sports consulting platform that leverages artificially generated data to enhance athletic performance, particularly in golf. The company specializes in the manufacturing of advanced golf simulators designed for practice purposes. These simulators utilize high-speed cameras and radar technology to measure and analyze critical aspects of a golfer's performance, including club and ball dynamics, as well as swing mechanics. By visually presenting the data, Creatz enables golf instructors to provide targeted feedback and guidance, helping golfers improve their skills and overall game.
PDC*line Pharma
Series B in 2021
PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, focused on developing innovative active immunotherapies for cancer. The company specializes in a proprietary allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line), which are loaded with cancer-specific antigens to stimulate a robust immune response. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, the company emerged from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. PDC*line Pharma aims to enhance cancer treatment efficacy by producing potent and scalable PDC lines that can boost antitumor responses, including the activation of neoantigens and specific cytotoxic T-cells, offering a more effective alternative to conventional vaccines.
TFJ
Series B in 2021
TFJ Global is a chemical company that specializes in the development of eco-friendly water-repellent products aimed at enhancing the functionality and durability of textiles. Utilizing non-fluorine nanotechnology, the company creates a protective layer that resists stains and maintains high antibacterial properties, even after multiple washes. This innovative approach allows customers to improve the utility, comfort, and longevity of various materials, including leather and wallpaper. Through its advanced chemical solutions, TFJ Global contributes to the textile industry by providing sustainable options that meet the demands of modern consumers.
Beyond Honeycomb
Series A in 2021
Beyond Honeycomb is a food-tech company focused on developing artificial intelligence-driven kitchen robots that replicate gourmet dishes. The robots utilize advanced AI and molecular sensor technology to analyze the cooking process at a molecular level, capturing detailed information about heat sources and temperature control used in professional kitchens. This innovative approach allows Beyond Honeycomb to recreate the texture and taste of high-quality chef-prepared meals, making gourmet dining experiences more accessible to a broader range of customers.
Ticaros
Series C in 2021
Ticaros is a biotechnology company focused on developing innovative immune anti-cancer therapies, specifically through the advancement of CAR-T cell therapy. The company’s approach involves enhancing the effectiveness of T cells by selectively inhibiting the CTLA4 function in cancer-specific T cells. This targeted modification aims to boost the ability of these T cells to eliminate tumors. By refining the CAR construct, Ticaros aims to increase the binding capacity of CAR-T cells to tumor cells, offering patients access to novel treatment options for relapsed and refractory cancer.
Space F
Series A in 2021
Space F is an application industry platform business company that researches and develops cell farming technology.
Sol Bio
Series A in 2021
SOL Bio is a biotechnology company focused on cancer diagnostics, specializing in the research and development of in vitro diagnostic products. Utilizing exosome isolation technology, the company aims to create early diagnostic tools for various cancers and chronic diseases. Its platform is designed to facilitate the immuno-isolation and analysis of exosomes, providing researchers and healthcare professionals with innovative solutions to address unmet medical needs. Through its advancements, SOL Bio seeks to enhance access to novel therapies and improve patient outcomes in the field of oncology.
Solmedix
Series A in 2021
Solmedix is a company focused on the development and commercialization of innovative medical devices aimed at enhancing treatment and diagnostic capabilities. Utilizing its MOSAIC Platform, Solmedix provides a range of services that include evaluating medical device concepts, producing prototypes, securing patents, and conducting empirical and preclinical research. The company supports the entire lifecycle of medical device development, from initial idea diagnosis to technology transfer and product launch. By offering these comprehensive services, Solmedix aims to facilitate the successful commercialization of startups with promising medical device concepts.
InCerebro
Seed Round in 2021
InCerebro is a pharmaceutical research and development company that offers drug development.
Pharos iBio
Series C in 2021
Pharos iBio Co. is a biotechnology company focused on the development of innovative treatments for rare and intractable diseases. Leveraging a novel drug development platform that incorporates big data and artificial intelligence technology, the company aims to address significant medical needs. Among its product candidates are PHI-101-AML, targeting refractory or relapsed acute myeloid leukemia; PHI-101-OC, designed for patients with platinum-resistant or refractory ovarian cancer; and PHI-101-TNBC, aimed at treating metastatic triple-negative breast cancer. Additionally, the company is advancing several other candidates, including PHI-201, PHI-301, and PHI-501. Through its targeted approach, Pharos iBio seeks to contribute to the advancement of treatment options in oncology.
Nemesis
Seed Round in 2021
Nemesis provides bio and medical device vendors and service providers with Intelligent biosignal processing solutions. Nemesis has technologies like biosensors, bio-signal processing, and wireless communication, which provide compact, low-power, and accurate semiconductor solutions that anyone can use. Nemesis semiconductor-based intelligent bio signal processing solution can be expanded to diagnose biomarkers in areas such as heart rate, electrocardiogram, blood pressure, and virus detection. Nemesis will do everything possible to improve the quality of our partners' products and services as a result of this.
Panolos Bioscience
Series A in 2021
Panolos Bioscience is a biotechnology firm focused on developing biological drugs specifically for cancer therapy. The company has created a multi-specific drug creation platform that utilizes anti-angiogenesis-based artifact re-targeting tri-specifics, commonly referred to as ART. This innovative approach aims to reduce the side effects associated with traditional single-target protein therapeutics. By employing a multi-targeting strategy, Panolos Bioscience not only enhances the efficacy of cancer treatment but also facilitates the expansion of new drug pipelines, ultimately providing patients with access to novel therapies for cancer.
WASHSWAT
Series B in 2021
Washswat Inc. is a South Korean company established in 2015 that specializes in on-demand mobile laundry services. Based in Seoul, it operates through a network of specialized facilities and personnel that handle washing and drying. Initially launched in the Gangnam area, known for its concentration of high-end cleaners, Washswat has strategically expanded its services to various regions, including Seongnam, Hanam, Goyang, Gwangmyeong, Yongin, Suwon, Anyang, and Gwacheon, becoming a leader in mobile laundry services in Korea. The company utilizes IT technology to enhance its offerings, providing customers with a mobile application that allows them to track their laundry process and schedule pickups and deliveries from their doorstep. Washswat's meticulous approach ensures that every item is carefully recorded to prevent loss, thereby delivering a reliable service tailored to meet customer needs.
Wefun
Series B in 2021
Wefun is a company focused on managing office snacks, offering a diverse selection to meet the tastes of employees. They employ a dedicated snack curator who conducts personalized consultations to understand client preferences and recommend new products. This tailored approach allows businesses to order weekly snacks that align with the specific tastes of their workforce, enhancing the overall workplace experience.
Nexel
Series B in 2021
Nexel is a biotechnology research firm focused on advancing drug discovery and biotherapeutics. The company specializes in developing high-quality induced pluripotent stem cell (iPSC) products using embryonic stem cell technology. By providing innovative solutions and drug discovery pipelines, Nexel aims to address unmet medical needs and enhance therapeutic options for various diseases.
Localstitch
Series A in 2021
Localstitch, founded in 2013 and based in South Korea, operates as a provider of shared office and residential spaces. The company aims to create environments where individuals can live, work, and launch businesses. By designing and managing flexible spaces, Localstitch facilitates collaboration among professionals while offering affordable rates that alleviate the financial burdens often associated with urban living. This approach allows clients to concentrate on their creative endeavors in a supportive community setting.
Rounded
Series A in 2021
Rounded is an art creator platform that sells living, furniture, and kitchen products.
Onegene Biotechnology
Series A in 2021
Onegene Biotechnology is a biotechnology company focused on developing innovative protein-based therapeutics aimed at treating cancer, metabolic, and inflammatory diseases. The company utilizes advanced protein conjugation technology, which involves the connection of separate proteins to create recombinant proteins through post-translational fusion. This approach enables the production of complex proteins with large molecular weights, facilitating the development of multispecific drugs that target multiple pathways simultaneously. Onegene's unique ability to combine various molecular types, including Fab fragments, scFv, sdAb, peptides, cytokines, and enzymes, allows for unprecedented design flexibility and optimized physical properties. Consequently, this innovation expands the potential for effective treatments for complex and multifactorial diseases, offering prolonged benefits for patients.
Apitbio
Series A in 2021
APITBIO is a biotechnology company focused on the research and development of antibody therapeutics, particularly in the field of anti-cancer drugs. The company utilizes a specialized platform to create various types of antibodies, including monoclonal and double antibodies. Their process encompasses all stages from initial screening and discovery to optimization and production. By developing these innovative therapies, APITBIO aims to address the unmet medical needs of cancer patients and improve treatment options available in hospitals.
Influential
Series C in 2021
Influential Inc. is a company based in Seoul, South Korea, founded in 2008. It specializes in publishing books and audiobooks, and it also organizes lectures and seminars featuring industry experts for various organizations. The company offers subscription services for its online audiobooks, catering to a global audience seeking professional development and knowledge.
URBAN Digital Marketing
Seed Round in 2021
URBAN Digital Marketing is a full-service digital marketing firm.
Share It
Venture Round in 2021
Share It is an IT social network platform that offers space mediation services for idle schools.
DataCommand
Venture Round in 2021
DataCommand Inc. is a system software development company based in Seoul, South Korea, founded in 2017. The company specializes in developing and supplying data backup and recovery solutions, data replication technologies, and integrated data management systems. Aimed primarily at IT infrastructure firms, DataCommand addresses the challenges posed by the growing volume of data by offering technology that monitors the entire lifecycle of data—from generation to deletion. This approach not only ensures business continuity through immediate data access but also allows clients to implement flexible and efficient data protection strategies at lower costs.
H2K
Venture Round in 2021
H2K is an edutech company based in Daejeon, South Korea, that focuses on developing an artificial intelligence-driven mobile application for Korean language education aimed at infants and toddlers. The app employs a phonics method to deliver personalized curricula, integrating various educational games and real-time assessments to enhance the learning experience. By providing tailored programs, H2K enables young learners to acquire the Korean language effectively and efficiently.
OGQ
Venture Round in 2020
OGQ is a developer of a social creator platform that facilitates connections between creators and their fans, allowing creators to sell their works directly. The platform hosts a diverse array of content, including images, videos, music, stickers, illustrations, and graphics in various formats, such as PSD and AI. With over 14 million creators, including photographers, musicians, and illustrators, OGQ serves a global audience, with significant user bases in the United States, India, and Russia. The platform has achieved substantial popularity, boasting 240 million app downloads and 2.6 billion content downloads, while maintaining a high user rating of 4.6 on Google Play. OGQ supports content in 30 languages, providing users with high-definition materials for various applications, including messaging services and search platforms.
MACHBASE
Series C in 2020
Machbase Inc specializes in providing a columnar database management system designed to process time series log data generated by various machines within IT infrastructures, particularly in the context of the Internet of Things (IoT). The company offers different editions of its software, including an embedded edition for applications such as unified threat management and factory automation, and a standard edition focused on real-time data analysis for security management and energy management systems. Machbase's solutions enable the collection, storage, indexing, retrieval, analysis, and visualization of big data in real-time, catering to industries such as steel, automotive, pharmaceuticals, and logistics. Founded in 2016 and based in San Jose, California, Machbase aims to enhance corporate productivity by delivering integrated information management solutions that support quick adaptation to process innovations and operational changes.
Autotelic Bio
Series A in 2020
Autotelic Bio is a biotechnology company dedicated to researching and developing innovative anti-cancer drugs. The company aims to enhance the efficacy and reduce the side effects of existing oncology treatments by focusing on precise targeting and optimization of therapies. In addition to its primary focus on cancer, Autotelic Bio seeks to expand its research efforts into immuno-oncology drugs that may also address conditions such as diabetes, hypertension, and diseases affecting the central nervous system. Through its specialized approach, Autotelic Bio is committed to improving treatment options for patients facing various health challenges.
BnH Research
Series A in 2020
BnH Research is a drug development and research firm focused on creating therapeutics for patients with chronic conditions. The company specializes in verifying the efficacy of new drug candidates and improving patient outcomes. It provides contract-based research services aimed at validating drug efficacy data, addressing the unmet needs of pharmaceutical companies. Additionally, BnH Research develops drug candidates with a particular emphasis on reopening cortical plasticity, which aids clients in targeting central nervous system conditions such as Alzheimer's Disease, PTSD, addiction, amblyopia, and stroke. Through its innovative approach, BnH Research contributes to advancing therapeutic options for complex health issues.
Super Kitchen
Series A in 2020
Super Kitchen is a food store chain that specializes in offering a variety of products, including beef soups, tomato meatballs, and altari pickles. The company focuses on providing fresh and healthy ingredients along with refrigerated foods designed for side dishes. By curating recipes and meal options, Super Kitchen aims to enhance the dining experience for its customers, allowing them to enjoy new and flavorful delicacies each day.
Ubix Therapeutics
Series B in 2020
Ubix Therapeutics, Inc. is a research and development company based in Seoul, South Korea, focused on creating anti-cancer drugs through its innovative proteolysis targeting chimera platform technology. This approach employs inhibitor technology to degrade specific target proteins within cells, aiming to enhance therapeutic efficacy for various cancers. By binding to proteins associated with targeted diseases, Ubix Therapeutics seeks to provide effective and life-saving treatments for patients, thereby supporting medical professionals in their efforts to combat cancer.
SecuLetter
Series B in 2020
SecuLetter Co Ltd is a company focused on providing advanced solutions to combat cyber threats, including malware and phishing attacks. The company employs hybrid approaches that integrate both static and dynamic analysis to detect unknown attacks, even as cyber criminals increasingly try to conceal malicious content within emails. SecuLetter specializes in diagnosing and analyzing security vulnerabilities at the assembly level, which allows for a detailed examination of non-executable files, resulting in a high detection rate for security threats and vulnerabilities. Its primary business areas encompass email security, secure data transmission between networks, web service file protection, document centralization security, cloud support security, and security threat intelligence. The company's commitment to delivering fast and accurate diagnostics positions it as a leader in the cybersecurity field.
PDC*line Pharma
Series B in 2020
PDC*line Pharma is a clinical-stage biotech company based in France and Belgium, focused on developing innovative active immunotherapies for cancer. The company specializes in a proprietary allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line), which are loaded with cancer-specific antigens to stimulate a robust immune response. Founded in April 2014 in Grenoble by Laurent Levy and Joel Plumas, the company emerged from a research program at the French Blood Bank that developed the PDC line from a patient with PDC leukemia. PDC*line Pharma aims to enhance cancer treatment efficacy by producing potent and scalable PDC lines that can boost antitumor responses, including the activation of neoantigens and specific cytotoxic T-cells, offering a more effective alternative to conventional vaccines.
Funda
Series B in 2020
Funda is a P2P finance service that connects multiple investors to sound stores that need funds and creates a financial service.
Curacle
Venture Round in 2020
Curacle is a biotechnology company focused on developing innovative drugs aimed at treating incurable diseases associated with the aging process and damage to blood vessels. Utilizing advanced technologies, Curacle seeks to address medical conditions that result from the destruction of blood vessels, which are often linked to various age-related ailments. The company's commitment to research and development positions it at the forefront of addressing significant health challenges through novel therapeutic solutions.
ASIC Land
Venture Round in 2020
ASIC Land develops technology that transcends the barriers and produces chips in the SoC, front-end, DFT, and back-end sectors.
Three Friends
Venture Round in 2020
Three Friends provides online and mobile accounting and tax processing automation services, specifically designed to assist small business owners. The company operates an artificial intelligence and big data platform that enables businesses to track performance, analyze sales and purchasing data, and manage cash flow. By employing various analysis, prediction, and recommendation techniques, Three Friends helps businesses understand their financial position in the market, facilitating better decision-making and efficient financial management.
Clecell
Venture Round in 2020
Clecell is a biotechnology company that focuses on bioprinting and tissue engineering. It specializes in the development of artificial tissues, including human skin models and respiratory epithelium, utilizing proprietary 3D bioprinting technology. By creating these advanced tissue models, Clecell aims to help clients prevent infections and tissue injuries through the implementation of the mucociliary elevator, which enhances protective functions of the respiratory system. Through its innovative approaches, Clecell contributes to advancements in biomedical research and therapeutic applications.
VR ZONE
Venture Round in 2020
VR ZONE operates a virtual reality theme park designed to create an immersive and futuristic atmosphere, featuring spaceship capsules and unique structures. The company specializes in developing and selling content and simulators that allow multiple users to engage simultaneously, enhancing the overall experience. By combining interactive storytelling with advanced technology, VR ZONE aims to provide an engaging environment where visitors can enjoy collaborative gameplay and fully immerse themselves in early narratives.
Hey Joyce
Seed Round in 2019
Hey Joyce is a women's career growth and problem-solving management consulting platform that connects women online.
Gluup
Series A in 2019
Gluup is a branding agency that focuses on research and development as well as brand marketing. It operates a brand commerce platform designed to build and promote various brands, particularly in the food and beverage sector. The company specializes in home meal replacement products and functions as a distributor, offering business-to-business-to-consumer solutions. By leveraging various online and offline channels, Gluup provides customers with a diverse range of products under a single platform, enhancing accessibility and convenience.
Localstitch
Seed Round in 2019
Localstitch, founded in 2013 and based in South Korea, operates as a provider of shared office and residential spaces. The company aims to create environments where individuals can live, work, and launch businesses. By designing and managing flexible spaces, Localstitch facilitates collaboration among professionals while offering affordable rates that alleviate the financial burdens often associated with urban living. This approach allows clients to concentrate on their creative endeavors in a supportive community setting.
Logispot
Series B in 2019
Logispot is a South Korean company founded in 2016 that specializes in digital logistics and freight transport services. It operates a platform designed to streamline the fragmented cargo transportation market by offering integrated transport management and efficient handling of incoming and outgoing shipments. The platform also facilitates seamless integration with customers' internal systems, ensuring a hassle-free experience in the movement of goods and services. By providing systematic functions, Logispot aims to enhance the efficiency and convenience of logistics operations for its clients.
TWC
Series A in 2019
TWC provides IT solutions, HR, consulting and optimized business operation services by incorporating artificial intelligence.
Oncorus
Series B in 2019
Oncorus, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative viral immunotherapies for cancer treatment. The company's lead candidate, ONCR-177, utilizes an oncolytic herpes simplex virus type 1 platform and is currently in Phase I clinical trials aimed at treating various cancers. In addition to ONCR-177, Oncorus is advancing the ONCR-GBM program for brain cancer and exploring synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. The company has entered a collaboration with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 in combination with Merck’s immunotherapy. Founded in 2015 and headquartered in Cambridge, Massachusetts, Oncorus is committed to advancing cancer care and has pledged to support cancer research and healthcare initiatives in developing regions through corporate philanthropy.
I-ON Digital
Venture Round in 2019
I-ON Digital Corp. is a software development company headquartered in Seoul, South Korea, specializing in unstructured data management and digital marketing solutions. The company provides a range of enterprise content management systems, including I-ON Content Server and I-ON Digital Asset Management System, alongside digital experience solutions such as web analytics and mobile contract platforms. I-ON Digital also offers smart mobility and analytics tools, catering to clients in various regions including South Korea, Japan, and Southeast Asia. Its energy management solutions aim to optimize electricity consumption through customizable demand response systems and a proprietary predictive analytics engine. Founded in 1999, I-ON Digital has evolved to address diverse market needs, including sports and IT convergence services that enhance the management of professional sports events.
Wing Eat
Venture Round in 2019
Wing Eat is an online food market that operates a retail platform focused on delivering high-quality food products directly to customers. The company specializes in ready-to-eat meals, pet foods, and various household items, ensuring that users have access to fresh and quality products conveniently delivered to their doorstep. Through its platform, Wing Eat aims to enhance the online shopping experience for consumers seeking reliable and accessible food options.
Immunomax
Venture Round in 2019
Immunomax is a biotechnology company focused on developing immunology-based biopharmaceuticals, particularly in the field of anti-cancer therapies. The company specializes in allogeneic gamma delta CAR-T cell therapies, which aim to enhance the immune system's ability to combat cancer. Additionally, Immunomax is involved in the production of animal cell lines designed for high-efficiency biopharmaceutical production. Through its innovative approach, the company seeks to empower healthcare professionals to improve patient outcomes by bolstering immune responses against various diseases.
GenoBio
Venture Round in 2018
GenoBio is a company focused on advancing medical technology for non-invasive liquid biopsy research. It specializes in ultra-sensitive genomic tools that facilitate the accurate and cost-effective detection of genetic variations associated with cancer, inherited diseases, and infectious diseases. By providing these advanced technologies, GenoBio enables research institutions and laboratories to conduct precise biopsies, enhancing their ability to study and diagnose a variety of health conditions.
Mr. Milk
Venture Round in 2018
Mr. Milk is a manufacturer of dairy products, focused on providing reliable and fresh options for consumers. The company produces a range of items, including yogurt, cheese, and ice cream, all made from raw milk. This commitment to quality ensures that customers have access to a healthy and diverse selection of dairy products.
JI Tech
Venture Round in 2018
JI Tech is a domestic manufacturer specializing in ultra-precision semiconductor compounds. Established in 2014, the company focuses on producing ultra-fine precursors for semiconductors alongside plasticized material manufacturing. Its product range includes precursors, mask cases, and additional semiconductor-related products. JI Tech has achieved consistent sales and profitability through ongoing technological development and effective customer engagement. In recognition of its success, the company was named a global small giant in Jeollabuk-do in 2021.
Stat
Venture Round in 2018
Stat & Co develops a gaming information platform that provides its users with the stats about baseball and other sports. The company's platform specializes in managing bowling game records, baseball clubs, a platform for badminton players, and a sports e-commerce website.
H9Pitch
Venture Round in 2018
H9Pitch Studio is a design studio focused on the sports sector and various cultures. It provides multimedia design services tailored to both domestic amateur and professional sports industries. The studio specializes in concept origination and creative direction, alongside offering videography and photography services. Additionally, H9Pitch Studio is involved in event planning and exhibition services, ensuring comprehensive support for clients within the sports community.
Monolith
Seed Round in 2017
Monolith Inc., founded in 2014 and based in Jeju, South Korea, specializes in the development of mobile games. Additionally, the company focuses on creating smart parks that integrate technology with play spaces for children, offering innovative recreational solutions. Through its dual approach, Monolith aims to enhance children's play experiences while leveraging technological advancements in its gaming and park designs.
OTD
Series A in 2017
OTD operates a diverse portfolio of gourmet restaurants and food courts throughout South Korea, primarily located in office buildings and shopping malls. The company focuses on delivering a variety of dining options under multiple brands, catering to the tastes of the general public while maintaining affordable pricing. By creating vibrant food courts that showcase different culinary offerings, OTD aims to enhance the dining experience for customers seeking convenience and quality.
Woman’s Talk
Venture Round in 2017
Woman’s Talk is viewed by its users as a ‘friendly’ platform for the way in which it provides users with pricing and product related information. A key factor in the success of the business is the requirement for product brands to provide their most competitive price and product guarantee. Woman’s Talk in return provides a lower service fee compared to traditional distribution services whilst also providing the full marketing support required to promote the product.
Boud
Venture Round in 2017
Boud is a design company that merges design and technology to enhance user experiences globally. The firm operates a design studio that provides brand consulting, product design, and place design services. Boud focuses on brand strategy and visualization, as well as product design strategy, ensuring a comprehensive approach to brand experiences. By coordinating colors, materials, and finishes, the company supports stable production while helping businesses establish a strong market presence. Boud is dedicated to creating meaningful value through innovative ideas, guiding clients from initial concepts to fully realized visual identities and products or spaces.
Suji's Korean Cuisine
Venture Round in 2017
Suji's Korean Cuisine offers change of ready for retail, ready to eat food and services.
Jeju Beer
Series A in 2016
Jeju Beer Company, Limited, founded in 2015 and based in Jeju, South Korea, specializes in the production of beer. As a brewery, it operates within the alcoholic beverage manufacturing industry, focusing on crafting unique brews that reflect the local culture and environment. The company aims to establish a strong presence in the market by offering quality products that appeal to both local and international consumers.
VNPT EPAY
Acquisition in 2016
VNPT EPay is a provider of electronic payment services focused on delivering advanced technology solutions for internet and mobile users, as well as banks. The company specializes in developing an online payment portal that facilitates various financial transactions. Its offerings include an online payment gateway, interbank money transfer services, deposit codes, and electronic wallets. By providing these services, VNPT EPay enables customers to efficiently manage their daily financial activities, enhancing convenience and accessibility in the digital payment landscape.
VRotein
Venture Round in 2016
VRotein Inc. is a company based in Gyeonggi-do, South Korea, that specializes in designing and developing virtual reality games. Founded in 2012, VRotein offers a comprehensive solution tailored for the virtual reality arcade industry. The company's focus is on creating engaging and immersive gaming experiences, positioning itself as a key player in the growing market of virtual reality entertainment.
CEFO
Venture Round in 2015
CEFO is a company focused on the research, development, and commercialization of stem cell therapy. It specializes in creating biomedical products that support the advancement of this field. The company's offerings include primary cultured cells, cell culture fluid, collagenase, and storage solutions for cell freezing. These products are designed to assist researchers in developing regenerative medicine, thereby facilitating innovation in stem cell applications. Through its commitment to developing essential tools for stem cell research, CEFO aims to contribute to the progress of regenerative therapies.
NovMetapharma Company
Venture Round in 2014
NovMetaPharma Co., Ltd. is a pharmaceutical company focused on researching and developing new treatments for metabolic diseases, which pose significant health risks due to aging populations and dietary changes. The company is actively engaged in the development of a therapeutic agent currently in Phase 2a clinical trials aimed at treating Type 2 diabetes and obesity. In addition to these primary targets, NovMetaPharma is also working on therapeutic agents for Alzheimer's disease, immune system disorders, osteoporosis, and non-alcoholic fatty liver disease. By leveraging research collaborations, particularly with renowned institutions such as the VA Institute, NovMetaPharma aims to transform innovative research into effective medications, addressing the growing need for safer and more effective treatment options in the metabolic disease sector.
ArenaCast
Venture Round in 2014
ArenaCast is a rapidly growing global provider of an interactive platform focused on esports, gaming, and over-the-top (OTT) digital content. The company has developed a gaming platform that integrates streaming services with gaming experiences, positioning itself within the evolving landscape of Web 3.0 and the metaverse. By offering a unique combination of features, ArenaCast enables users to engage with a variety of digital content, enhancing the interactive experience for both gamers and esports enthusiasts.
Intin
Venture Round in 2013
INTIN is engaged in the research, development, and sale of digital healthcare products. The company specializes in self-diagnostic medical devices that aim to enhance healthcare accessibility and efficiency. Its flagship product allows users to assess sperm count and activity status through a smartphone application, while also providing insights into ovulation dates. In addition to this, INTIN offers a range of other medical devices, including a non-contact thermometer and an ovulation analyzer. These innovations enable users to conduct essential health checks at home, ultimately saving time and reducing the need for hospital visits for related medical assessments.
BNH Cosmetics
Venture Round in 2013
BNH Cosmetics, based in Seoul, South Korea, is a prominent player in the K-beauty industry, specializing in a diverse range of products including skincare, suncare, mask packs, base makeup, eye makeup, and makeup tools. The company is dedicated to innovation, consistently developing products that aim to enhance the customer experience and differentiate itself within the global market. Through its transformative initiatives, BNH Cosmetics seeks to drive progress in the beauty industry while establishing itself as a leading competitor.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.